Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse

actpapertier 1link oklink-only

Open source

ID
3ceeebfbbf6f4448
Source org
ACBS
Author
Published
OA status
DOI
PMID
PMCID
Citations

Tags

Verification

Automated checks only — not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:3ceeebfbbf6f4448,
  title = {Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., \& Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse},
  journal = {ACBS},
  url = {https://contextualscience.org/act_randomized_controlled_trials_1986_to_present}
}

RIS

TY  - JOUR
TI  - Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse
PB  - ACBS
UR  - https://contextualscience.org/act_randomized_controlled_trials_1986_to_present
ER  - 

APA

Depression and quality of life in OCD; ACT vs SSRIs. N=27. Ebrahimi, A., Nasre Esfahan, E., Akuchekian, S., Izadi, R., Shaneh, E., & Mahaki, B. (2022). A randomized clinical trial: Comparison of group acceptance and commitment therapy with drug on quality of life and depression in patients with obse. (n.d.). ACBS. https://contextualscience.org/act_randomized_controlled_trials_1986_to_present

Related entries